Free Trial

Avid Bioservices (CDMO) News Today

$9.47
+0.02 (+0.21%)
(As of 12:31 PM ET)
Avid Bioservices logo with Medical background
Avid Bioservices (NASDAQ:CDMO) Shares Up 3.7%
Avid Bioservices (NASDAQ:CDMO) Trading Up 3.7%
Avid Bioservices logo with Medical background
BNP Paribas Financial Markets Buys 104,573 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)
BNP Paribas Financial Markets boosted its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 50.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 310,559 shares of the biopharmaceutical company's stock afte
Avid Bioservices logo with Medical background
Avid Bioservices, Inc. (NASDAQ:CDMO) Sees Large Decrease in Short Interest
Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) was the recipient of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 12,360,000 shares, a drop of 18.0% from the June 15th total of 15,080,000 shares. Based on an average daily trading volume, of 1,010,000 shares, the short-interest ratio is currently 12.2 days.
Avid Bioservices logo with Medical background
Avid Bioservices (NASDAQ:CDMO) Trading Up 9.5%
Avid Bioservices (NASDAQ:CDMO) Stock Price Up 9.5%
Avid Bioservices logo with Medical background
Avid Bioservices' (CDMO) "Outperform" Rating Reiterated at Royal Bank of Canada
Royal Bank of Canada reissued an "outperform" rating and set a $8.00 target price on shares of Avid Bioservices in a report on Wednesday.
Avid Bioservices logo with Medical background
Avid Bioservices, Inc. (NASDAQ:CDMO) Short Interest Update
Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) was the recipient of a significant increase in short interest in June. As of June 15th, there was short interest totalling 15,080,000 shares, an increase of 31.0% from the May 31st total of 11,510,000 shares. Based on an average daily volume of 1,030,000 shares, the days-to-cover ratio is currently 14.6 days.
Avid Bioservices logo with Medical background
Wellington Management Group LLP Purchases 315,600 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)
Wellington Management Group LLP boosted its holdings in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 27.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,478,842 shares of the biopharmaceutical company's stock after buying an addit
Stephens Inc. AR Grows Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO)
Stephens Inc. AR grew its stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 62.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 253,368 shares of the biopharmaceutical company's stock after buyin
Avid Bioservices, Inc. (NASDAQ:CDMO) Sees Significant Increase in Short Interest
Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) was the target of a large increase in short interest in May. As of May 15th, there was short interest totalling 11,860,000 shares, an increase of 7.2% from the April 30th total of 11,060,000 shares. Based on an average trading volume of 1,390,000 shares, the days-to-cover ratio is presently 8.5 days.
Avid Bioservices (NASDAQ:CDMO) Shares Down 6.1%
Avid Bioservices (NASDAQ:CDMO) Trading Down 6.1%
Trexquant Investment LP Takes $1.26 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO)
Trexquant Investment LP purchased a new stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 193,768 shares of the biopharmaceutical company's stock, valued at approximately $1,259,000.
BNP Paribas Financial Markets Purchases 149,737 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)
BNP Paribas Financial Markets increased its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 266.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 205,986 shares of the biopharmaceutical company's stock after purchasing an addition
Great Lakes Advisors LLC Sells 86,814 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)
Great Lakes Advisors LLC trimmed its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 56.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,195 shares of the biopharmaceut
Avid Bioservices (NASDAQ:CDMO) Shares Gap Down to $9.28
Avid Bioservices (NASDAQ:CDMO) Shares Gap Down to $9.28
Jump Financial LLC Makes New $936,000 Investment in Avid Bioservices, Inc. (NASDAQ:CDMO)
Jump Financial LLC purchased a new position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 144,049 shares of the biopha
Avid Bioservices logo with Medical background
Avid Bioservices (NASDAQ:CDMO) Trading Up 4%
Avid Bioservices (NASDAQ:CDMO) Trading 4% Higher
Short Interest in Avid Bioservices, Inc. (NASDAQ:CDMO) Increases By 7.2%
Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 11,060,000 shares, a growth of 7.2% from the April 15th total of 10,320,000 shares. Based on an average daily volume of 1,380,000 shares, the days-to-cover ratio is presently 8.0 days.
Avid Bioservices, Inc. (NASDAQ:CDMO) Position Increased by Roubaix Capital LLC
Roubaix Capital LLC raised its holdings in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 374.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 369,158 shares of the biopharmaceutical comp
New York State Common Retirement Fund Has $4.93 Million Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO)
New York State Common Retirement Fund cut its position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 23.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 758,259 shares of the biophar
Avid Bioservices (NASDAQ:CDMO) Price Target Raised to $8.00
Royal Bank of Canada boosted their target price on shares of Avid Bioservices from $7.00 to $8.00 and gave the company an "outperform" rating in a research note on Tuesday.
Q3 2024 Avid Bioservices Inc Earnings Call
Federated Hermes Inc. Takes Position in Avid Bioservices, Inc. (NASDAQ:CDMO)
Federated Hermes Inc. purchased a new position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 321,477 shares of the biopharma
Jennison Associates LLC Decreases Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO)
Jennison Associates LLC decreased its holdings in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 95.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 101,147 shares o
Avid Bioservices, Inc. (NASDAQ:CDMO) Short Interest Down 6.7% in March
Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 10,110,000 shares, a decline of 6.7% from the March 15th total of 10,840,000 shares. Based on an average trading volume of 1,330,000 shares, the days-to-cover ratio is currently 7.6 days.
Wellington Management Group LLP Has $10.98 Million Stock Position in Avid Bioservices, Inc. (NASDAQ:CDMO)
Wellington Management Group LLP boosted its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 72.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,163,242 shares of the biop
CDMO Dec 2024 10.000 call
Avid Bioservices, Inc. (NASDAQ:CDMO) Sees Large Increase in Short Interest
Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) was the target of a large growth in short interest in February. As of February 29th, there was short interest totalling 6,590,000 shares, a growth of 16.6% from the February 14th total of 5,650,000 shares. Based on an average daily trading volume, of 1,660,000 shares, the days-to-cover ratio is presently 4.0 days.
CDMO Apr 2024 15.000 call
CDMO Dec 2024 2.500 call
Get Avid Bioservices News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter.

Kiss of death from Joe Biden (Ad)

As you’ll discover, behind closed doors in D.C. the elites have manufactured a shocking new economic and social crisis that threatens everything. Elon Musk calls it “staggering.”

To get all the details, click here to stream this new documentary.

CDMO Media Mentions By Week

CDMO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDMO
News Sentiment

0.23

0.58

Average
Medical
News Sentiment

CDMO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDMO Articles
This Week

4

2

CDMO Articles
Average Week

Get Avid Bioservices News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CDMO) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners